Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents

Sulphonylurea compounds have versatile activities such as antidiabetic, diuretic, herbicide, oncolytic, antimalarial, antifungal and anticancer. The present study describes the design, synthesis and in vivo testing of novel glycosylated aryl sulfonylurea compounds as antihyperglycaemic agents in str...

Full description

Bibliographic Details
Main Authors: Ghadeer A. R. Y. Suaifan, Mayadah B. Shehadeh, Rula M. Darwish, Hebah Al-Ijel, Vincenzo Abbate
Format: Article
Language:English
Published: MDPI AG 2015-11-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/20/11/19676
_version_ 1818066880869433344
author Ghadeer A. R. Y. Suaifan
Mayadah B. Shehadeh
Rula M. Darwish
Hebah Al-Ijel
Vincenzo Abbate
author_facet Ghadeer A. R. Y. Suaifan
Mayadah B. Shehadeh
Rula M. Darwish
Hebah Al-Ijel
Vincenzo Abbate
author_sort Ghadeer A. R. Y. Suaifan
collection DOAJ
description Sulphonylurea compounds have versatile activities such as antidiabetic, diuretic, herbicide, oncolytic, antimalarial, antifungal and anticancer. The present study describes the design, synthesis and in vivo testing of novel glycosylated aryl sulfonylurea compounds as antihyperglycaemic agents in streptozocine-induced diabetic mice. The rational for the introduction of the glucosamine moiety is to enhance selective drug uptake by pancreatic β-cells in order to decrease the cardiotoxic side effect commonly associated with sulfonylurea agents. 2-Deoxy-2-(4-chlorophenylsulfonylurea)-d-glucopyranose was found to be the most potent antihyperglycaemic agents among the synthesized compounds in diabetic mice. This investigation indicates the importance of this novel class as potential antihyperglycaemic agents.
first_indexed 2024-12-10T15:14:49Z
format Article
id doaj.art-ec6c930c88db44fea5071458dc7ba064
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-10T15:14:49Z
publishDate 2015-11-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-ec6c930c88db44fea5071458dc7ba0642022-12-22T01:43:50ZengMDPI AGMolecules1420-30492015-11-012011200632007810.3390/molecules201119676molecules201119676Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic AgentsGhadeer A. R. Y. Suaifan0Mayadah B. Shehadeh1Rula M. Darwish2Hebah Al-Ijel3Vincenzo Abbate4Department of Pharmaceutical Sciences, Faculty of Pharmacy, The University of Jordan, Amman 11942, JordanDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, The University of Jordan, Amman 11942, JordanDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, The University of Jordan, Amman 11942, JordanDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, The University of Jordan, Amman 11942, JordanInstitute of Pharmaceutical Science, King’s College London, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, UKSulphonylurea compounds have versatile activities such as antidiabetic, diuretic, herbicide, oncolytic, antimalarial, antifungal and anticancer. The present study describes the design, synthesis and in vivo testing of novel glycosylated aryl sulfonylurea compounds as antihyperglycaemic agents in streptozocine-induced diabetic mice. The rational for the introduction of the glucosamine moiety is to enhance selective drug uptake by pancreatic β-cells in order to decrease the cardiotoxic side effect commonly associated with sulfonylurea agents. 2-Deoxy-2-(4-chlorophenylsulfonylurea)-d-glucopyranose was found to be the most potent antihyperglycaemic agents among the synthesized compounds in diabetic mice. This investigation indicates the importance of this novel class as potential antihyperglycaemic agents.http://www.mdpi.com/1420-3049/20/11/19676sulphonylureaantihyperglycemic agentsglucosaminestreptozocine
spellingShingle Ghadeer A. R. Y. Suaifan
Mayadah B. Shehadeh
Rula M. Darwish
Hebah Al-Ijel
Vincenzo Abbate
Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents
Molecules
sulphonylurea
antihyperglycemic agents
glucosamine
streptozocine
title Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents
title_full Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents
title_fullStr Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents
title_full_unstemmed Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents
title_short Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents
title_sort design synthesis and in vivo evaluation of novel glycosylated sulfonylureas as antihyperglycemic agents
topic sulphonylurea
antihyperglycemic agents
glucosamine
streptozocine
url http://www.mdpi.com/1420-3049/20/11/19676
work_keys_str_mv AT ghadeerarysuaifan designsynthesisandinvivoevaluationofnovelglycosylatedsulfonylureasasantihyperglycemicagents
AT mayadahbshehadeh designsynthesisandinvivoevaluationofnovelglycosylatedsulfonylureasasantihyperglycemicagents
AT rulamdarwish designsynthesisandinvivoevaluationofnovelglycosylatedsulfonylureasasantihyperglycemicagents
AT hebahalijel designsynthesisandinvivoevaluationofnovelglycosylatedsulfonylureasasantihyperglycemicagents
AT vincenzoabbate designsynthesisandinvivoevaluationofnovelglycosylatedsulfonylureasasantihyperglycemicagents